Ledger.Open graph →
SEC Form D · filed July 30, 2012

Ultragenyx Pharmaceutical Inc

Offering
$30.1M
Sold
$15.1M
Exemption
—
Industry
Biotechnology
Location
Novato, CA
Type
—

People & firms on this filing (9)

William Aliski · Novato, CADirectorEmil Kakkis · NOVATO, CAExec · DirectorThomas A. Lewis · Mesquite, TXDirectorMarten Steen · Lausanne, V8DirectorPharmacy Portfolio Iii, L.L.C · Oak Brook, ILDirectorPharmacy Portfolio III Exchange, L.L.C · Oak Brook, ILDirectorEmil Kakkis · Novato, CAExec · DirectorEran Nadav · San Francisco, CADirectorBen Auspitz · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗